shall prevail. The objective of this MD&A is to present the information and the explanation of financial status and operating results as of the date hereof. However, the information provided in this MD&A
passed by not less than three-fourths of the total votes of the shareholders or proxies who are present at the meeting and have the right to vote, excluding those who have an interest in the transaction
passed by not less than three-fourths of the total votes of the shareholders or proxies who are present at the meeting and have the right to vote, excluding those who have an interest in the transaction
mn) New progressive license fee rate 0 – 100 0.125% 101 – 500 0.25% 501 – 1,000 0.5% 1,001 – 10,000 0.75% 10,001 – 25,000 1% 25,001 – 50,000 1.25% >50,000 1.5% At present, total regulatory fee composes
follows. 7.1 KT Medical Service Company Limited operates to provide health care facilities for patients with end-stage chronic kidney disease who receive replacement therapy with dialysis kidneys. Present
determined the purchase price of the shares considered from the value of the business through Discounted Cash Flow method. 7. Benefits Expected to be obtained by the Company from the Transaction At present
contract term. In this MDA material, we present financial income statement based on pre-TFRS for comparison with FY18. 2. In 2Q19, AIS received an allocation of 700MHz spectrum (2x10MHz bandwidth). The
conditions of the assets at the time of tender. In addition, the Company had always been trying to sell such Land and Buildings but no interested persons contacted. Until the present, the Company received a
assets at the time of tender. In addition, the Company had always been trying to sell such Land and Buildings but no interested persons contacted. Until the present, the Company received a letter
shall prevail. The objective of this MD&A is to present the information and the explanation of financial status and operating results as of the date hereof. However, the information provided in this MD&A